↓ Skip to main content

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

Overview of attention for article published in Orphanet Journal of Rare Diseases, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?
Published in
Orphanet Journal of Rare Diseases, September 2012
DOI 10.1186/1750-1172-7-72
Pubmed ID
Authors

Sophie Bouvresse, Laurence Valeyrie-Allanore, Nicolas Ortonne, Marie Pauline Konstantinou, Sylvia H Kardaun, Martine Bagot, Pierre Wolkenstein, Jean-Claude Roujeau

Abstract

Severe cutaneous adverse reactions to drugs (SCARs) include acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS) and epidermal necrolysis (Stevens-Johnson syndrome-toxic epidermal necrolysis [SJS-TEN]). Because of the varied initial presentation of such adverse drug reactions, diagnosis may be difficult and suggests overlap among SCARs. Overlapping SCARs are defined as cases fulfilling the criteria for definite or probable diagnosis of at least 2 ADRs according to scoring systems for AGEP, DRESS and SJS-TEN. We aimed to evaluate the prevalence of overlap among SCARs among cases in the referral hospital in France.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 2 3%
Portugal 1 1%
Unknown 77 96%

Demographic breakdown

Readers by professional status Count As %
Other 15 19%
Student > Postgraduate 10 13%
Researcher 8 10%
Student > Doctoral Student 8 10%
Student > Master 7 9%
Other 15 19%
Unknown 17 21%
Readers by discipline Count As %
Medicine and Dentistry 41 51%
Pharmacology, Toxicology and Pharmaceutical Science 7 9%
Biochemistry, Genetics and Molecular Biology 2 3%
Agricultural and Biological Sciences 2 3%
Business, Management and Accounting 1 1%
Other 5 6%
Unknown 22 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 August 2015.
All research outputs
#14,153,088
of 22,681,577 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,551
of 2,595 outputs
Outputs of similar age
#98,775
of 171,687 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#16
of 28 outputs
Altmetric has tracked 22,681,577 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,595 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,687 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.